advancing innovation to save lives

GHTC welcomes launch of first-ever WHO list of essential diagnostic tests

GHTC welcomes the publication today by the World Health Organization (WHO) of its first Essential Diagnostics List, a critical new tool to help guide governments on the vital diagnostic tests that should be made available through health care systems.
Learn More

Return On Innovation: Learn how global health R&D delivers for your state

Global health R&D matters globally and benefits you locally. Find out how US investments in global health R&D are paying economic and health dividends in your state.
View

Member Spotlight: HarvestPlus

HarvestPlus leads a global effort to improve vitamin and mineral nutrition and public health by developing and deploying staple food crops that are rich in vitamins and minerals.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PDF
PATH/Will Boase
GHTC WHA statement cited in Homeland Preparedness News

A joint statement developed by GHTC and delivered at the 71st World Health Assembly (WHA) was cited in an article in Homeland Preparedness News.

View
View All News & Events

Community Event

PATH/Gabe Bienczycki
Empathy: The Emperor’s New Clothes –– or Public Health’s Emerging Superhero?
Matchboxology, USAID Center for Accelerating Innovation and Impact
Learn More

Member Event

RESULTS International Conference
RESULTS
Learn More
View All Events
Better Health, Stronger Economies: Investing in Global Health Research & Development

R!A, in partnership with Aeras, the International AIDS Vaccine Initiative, the International Partnership for Microbicides and OneWorld Health, hosted a Capitol Hill briefing Nov. 15 on the role of product development partnerships (PDPs) in global health R&D.

Research!America
Read More
‘The biggest thing we are leaving behind is intellectual capital’

One of the most overlooked benefits of US-funded global health research is the training provided to scientists to do the work in their own communities.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide